Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-01-01 @ 1:16 AM
Study NCT ID:
NCT04829604
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-14
First Post:
2021-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
Sponsor:
Ambrx, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ACE-Breast-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None